TAE684 (NVP-TAE684)
2mM in DMSO
- Product Code: 239324
CAS:
761439-42-3
| Molecular Weight: | 614.20 g./mol | Molecular Formula: | C₃₀H₄₀ClN₇O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
TAE684 (NVP-TAE684) is a potent and selective inhibitor of the anaplastic lymphoma kinase (ALK). It is primarily used in research settings to study ALK-driven cancers, particularly non-small cell lung cancer (NSCLC) and anaplastic large cell lymphoma (ALCL), where ALK gene rearrangements play a key role in tumor development.
The compound demonstrates strong anti-tumor activity by blocking ALK phosphorylation and downstream signaling pathways such as STAT3, AKT, and ERK, leading to cell cycle arrest and apoptosis in ALK-positive cancer cells. Due to its high selectivity and efficacy in preclinical models, TAE684 has served as a critical tool compound for validating ALK as a therapeutic target and for guiding the development of clinically approved ALK inhibitors.
It is not used in clinical practice but remains valuable in laboratory research for understanding resistance mechanisms, combination therapies, and the biology of ALK-dependent tumors.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | €226.64 |
+
-
|
TAE684 (NVP-TAE684)
TAE684 (NVP-TAE684) is a potent and selective inhibitor of the anaplastic lymphoma kinase (ALK). It is primarily used in research settings to study ALK-driven cancers, particularly non-small cell lung cancer (NSCLC) and anaplastic large cell lymphoma (ALCL), where ALK gene rearrangements play a key role in tumor development.
The compound demonstrates strong anti-tumor activity by blocking ALK phosphorylation and downstream signaling pathways such as STAT3, AKT, and ERK, leading to cell cycle arrest and apoptosis in ALK-positive cancer cells. Due to its high selectivity and efficacy in preclinical models, TAE684 has served as a critical tool compound for validating ALK as a therapeutic target and for guiding the development of clinically approved ALK inhibitors.
It is not used in clinical practice but remains valuable in laboratory research for understanding resistance mechanisms, combination therapies, and the biology of ALK-dependent tumors.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :